Role of immunohistochemistry in the molecular classification of atypical teratoid/rhabdoid tumor
Child's Nervous System · 2025
DOI: 10.1007/s00381-025-07018-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Child's Nervous System, 2025. Verfasst von Rumela Nayak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bangalore, India. Hauptthemen laut MEDLINE: Rhabdoid Tumor, Teratoma, Immunohistochemistry, Biomarkers, Tumor. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Atypical teratoid/rhabdoid tumors (ATRTs) are rare, aggressive Central nervous system (CNS) tumors in young children with poor prognosis. Molecular subgrouping (ATRT-TYR, ATRT-SHH, ATRT-MYC) is crucial for understanding biology, guiding treatment, and predicting outcomes. This study assesses immunohistochemistry (IHC) as a surrogate for molecular subgrouping and is the second study to analyze histomorphological patterns across subgroups. METHODS: The study analyzed 39 histopathologically confirmed ATRT cases over 15 years. Clinical and radiological data were obtained from case records, and H&E and IHC slides were reviewed. IHC markers-SOX-11 for ATRT-SHH, C-MYC for ATRT-MYC, and tyrosinase for ATRT-TYR-were used for molecular subgrouping. Subgrouping results were correlated with clinical, pathological, and survival data available in the literature. RESULTS: The most common subgroup was ATRT-SHH (41%), followed by ATRT-MYC (33%) and ATRT-TYR (23%). ATRT-SHH predominantly occurred in children ≤ 3 years and showed diverse cell morphology. ATRT-MYC had the widest age range, including adults, and a higher supratentorial prevalence. ATRT-TYR was common in infants and predominantly infratentorial. Rhabdoid cells were the most common cell type, varying across subgroups. Survival analysis (on a limited follow-up cohort of n = 11) suggested ATRT-MYC may be the most aggressive subtype, although this finding is limited by sample size and heterogeneity of treatment. CONCLUSION: Immunohistochemistry (IHC) based classification of ATRT aligned with known molecular and clinicopathological patterns. These alignment with known patterns suggests that the IHC-based classification can be used in routine practice as a cost-effective alternative method to methylation profiling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bangalore, India.
- Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bangalore, India. shilpagk.rao@gmail.com.
- Department of Pathology, Gouri Devi Institute of Medical Sciences and Hospital, Durgapur, West Bengal, India.
- Department of Neurosurgery, National Institute of Mental Health and Neurosciences, Bangalore, India.
- Department of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bangalore, India.
ORCID-Profile: Rumela Nayak, Shilpa Rao, Abhishek Chowdhury
Zitieren
APA
Nayak, R., Rao, S., Chowdhury, A., A, A., Singh, G. J., & Saini, J. (2025). Role of immunohistochemistry in the molecular classification of atypical teratoid/rhabdoid tumor. Child's Nervous System. https://doi.org/10.1007/s00381-025-07018-6
Vancouver
Nayak R, Rao S, Chowdhury A, A A, Singh GJ, Saini J. Role of immunohistochemistry in the molecular classification of atypical teratoid/rhabdoid tumor. Child's Nervous System. 2025. doi:10.1007/s00381-025-07018-6
BibTeX
@article{Nayak2025,
author = {Nayak, Rumela and Rao, Shilpa and Chowdhury, Abhishek and A, Arivazhagan and Singh, Gyani Jail and Saini, Jitender},
title = {Role of immunohistochemistry in the molecular classification of atypical teratoid/rhabdoid tumor},
journal = {Child's Nervous System},
year = {2025},
doi = {10.1007/s00381-025-07018-6}
}
EUVIMED